News

Investing.com -- Airbus reported a sharp rise in second-quarter earnings on Wednesday, driven by higher commercial aircraft deliveries and improved performance across its businesses, while maintaining its full-year 2026 guidance.

APH's Q2 earnings and revenues surge on strong IT datacom demand, broad organic growth and acquisitions, while record orders fuel upbeat Q3 guidance.

KLA's fiscal Q4 earnings beat estimates as AI infrastructure, foundry/logic and process control demand lift revenues 15.2% and strengthen its outlook.

Ram, Jeep, and Fiat parent company Stellantis reported decent first-half results on Thursday morning, but only reaffirmed its prior guidance. Investors clearly want more from CEO Antonio Filosa's turnaround plan.

The company reported a 557% annual increase in operating income in the second quarter.

Two trading sessions reached opposite conclusions about the same report. One of them had the better argument.

Arch Capital beats Q2 earnings estimates as investment income offsets catastrophe pressure, despite lower premiums and underwriting profit.

Pfizer heads into Q2 earnings with expectations for growth in key products, COVID headwinds, and guidance updates that could shape its outlook.

Biogen tops Q2 earnings and revenue estimates as growth drugs fuel sales, offset MS declines, and support a higher 2026 revenue and EPS outlook.

GE HealthCare reports earnings per share of $1.13 from sales of $5.3 billion. Wall Street was looking for $1.04 a share and $5.3 billion, respectively.

SoFi crushed revenue estimates and raised its top-line outlook, yet shares cratered 10% anyway as sellers zeroed in on one number management refused to budge on.

The Tim Cook era was a highly profitable one for Apple shareholders.

(Bloomberg) -- As Big Tech barrels toward trillions of dollars of planned spending on AI, a key cog in credit markets is showing signs of pressure. That, in turn, is lifting the cost of financing artificial intelligence while offering an early look at potential winners and losers.Most Read from BloombergUS Intercepts Iran Attack on Bases, Puncturing Days of CalmSK Hynix Profit Disappoints, Spending Soars to $31 BillionApple Set to Make Big Smart Home Push With Siri AI at CenterNvidia’s $750 Bill

It takes a lot for artificial-intelligence trade-related companies to impress Wall Street with earnings or guidance these days, but Teradyne has done just that. Shares of the semiconductor test equipment manufacturer rose 9% to $338.43 on Wednesday after the company late Tuesday reported better-than-expected second-quarter earnings and solid quarterly guidance. Teradyne posted adjusted earnings of $2.47 a share in the second quarter, up from 57 cents a year ago and well above Wall Street’s expectation of $2.09.

S&P Global highlights AI growth, benchmark strength and higher buybacks after the Mobility spin-off as it targets profitable growth across key businesses.

Medicare beneficiaries may face higher premiums next year for their Part D drug plans, as the federal government plans to end subsidies that helped mitigate price increases in the program. The Trump administration will not continue the subsidies beyond 2026, The Wall Street Journal reported. About 25 million Medicare recipients are enrolled in a stand-alone Part D plan for their drug coverage.

Amphenol (APH) delivered earnings and revenue surprises of +13.45% and +5.51%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Lucid Stock Rallies After Prince Alwaleed Discloses a 5% Stake

Ford surged past both Detroit and Silicon Valley rivals in a single session, driven by a confluence of factors that rarely align this cleanly for a legacy automaker carrying fresh EV write-downs and a bruising GAAP loss.

Bloom Energy posted blowout second-quarter results.

Qualcomm said on Wednesday it has signed a long-term deal to supply ‌chips for German luxury automaker BMW's future ‌digital cockpit and advanced driver-assistance systems through the next decade. The ​agreement comes as competition intensifies in the automated driving market, with Nvidia and Mobileye Global also aiming to supply chips and software platforms to automakers. • The ‌deal includes Qualcomm's ⁠Snapdragon Digital Chassis solutions, including cockpit processors, automated driving chips and AI accelerators, which ⁠the companies said would establish the hardware basis for BMW's AI-led platforms.

Investing.com -- Citi upgraded Ford Motor to Buy from Neutral and raised its price target to $20 from $19, saying improving F-Series pickup production, easing warranty costs and better aluminum supply are driving a positive shift in the automaker's earnings outlook.

Investing.com -- Capital Economics told clients in a note Wednesday that the recent selloff in AI-linked tech giants is being driven by fear rather than hard evidence, and it expects the rally to resume, at least for now.

Stock Market Today: The Dow Jones index dropped Wednesday ahead of the Fed decision and Fed Chair Warsh's comments. SK Hynix sold off.

Ford stock rose sharply on Wednesday morning after the Detroit automaker reported mixed second-quarter results and raised its full-year guidance, earnings a quick upgrade to buy from Citi. The analyst's note cited improving momentum and placed a price target at 20, 34% above where Ford stock ended Tuesday. Shares of Ford were up around 5.5% in Wednesday's premarket trading, according to MarketSurge.

Shares of Procter & Gamble declined in premarket trading Wednesday as Wall Street reacted to mixed quarterly earnings and underwhelming profit guidance from the consumer packaged goods company. Procter & Gamble posted core earnings of $1.43 a share for the fiscal fourth quarter, down from $1.48 a year ago but slightly above Wall Street expectations of $1.41. It was a mixed bag for Procter & Gamble’s product categories—which range from baby care to hair care.

Amazon reported its Q2 earnings after the bell on Thursday.

Amazon reported its Q2 earnings after the bell on Thursday.

Generac Holdings (GNRC) delivered earnings and revenue surprises of +49.23% and -0.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

July 29 () - GE HealthCare on Wednesday beat Wall Street estimates for second-quarter profit, helped by strong demand for its ‌diagnostic and imaging devices and refunds of tariffs imposed under U. Shares of the medical device maker rose 12% in premarket trading.